DDX3, a DEAD Box RNA Helicase with Tumor Growth–Suppressive Property and Transcriptional Regulation Activity of the p21waf1/cip1 Promoter, Is a Candidate Tumor Suppressor
Open Access
- 1 July 2006
- journal article
- Published by American Association for Cancer Research (AACR) in Cancer Research
- Vol. 66 (13), 6579-6588
- https://doi.org/10.1158/0008-5472.can-05-2415
Abstract
DDX3 is a DEAD box RNA helicase with diverse biological functions. Using colony formation assay, our results revealed that DDX3 inhibited the colony formation ability of various tumor cells, and this inhibition might be due to a reduced growth rate caused by DDX3. Additionally, we identified p21waf1/cip1, a cyclin-dependent kinase inhibitor, as a target gene of DDX3, and the up-regulation of p21waf1/cip1 expression accounted for the colony-suppressing activity of DDX3. Moreover, DDX3 exerted its transactivation function on p21waf1/cip1 promoter through an ATPase-dependent but helicase-independent mechanism, and the four Sp1 sites located within the −123 to −63 region, relative to the transcription start site of p21waf1/cip1 promoter, were essential for the response to DDX3. Furthermore, DDX3 interacted and cooperated with Sp1 to up-regulate the promoter activity of p21waf1/cip1. To determine the relevance of DDX3 in clinical cancers, the expression profile of DDX3 in various tumors was also examined. A declined expression of DDX3 mRNA and protein was found in ∼58% to 73% of hepatoma specimens, which led to the reduction of p21waf1/cip1 expression in a manner independent of p53 status. Additionally, an alteration of subcellular localization from nuclei to cytoplasm was also observed in >70% of cutaneous squamous cell carcinoma samples. Because DDX3 exhibits tumor suppressor functions, such as a growth-suppressive property and transcriptional activation of the p21waf1/cip1 promoter, and is inactivated through down-regulation of gene expression or alteration of subcellular localization in tumor cells, all these features together suggest that DDX3 might be a candidate tumor suppressor. (Cancer Res 2006; 66(13): 6579-88)Keywords
Other Versions
This publication has 48 references indexed in Scilit:
- DDX3, a DEAD box RNA helicase, is deregulated in hepatitis virus-associated hepatocellular carcinoma and is involved in cell growth controlOncogene, 2005
- Integrative genomics based identification of potential human hepatocarcinogenesis-associated cell cycle regulators: RHAMM as an exampleBiochemical and Biophysical Research Communications, 2005
- The DEAD box protein p68: a novel transcriptional coactivator of the p53 tumour suppressorThe EMBO Journal, 2005
- Requirement of DDX3 DEAD Box RNA Helicase for HIV-1 Rev-RRE Export FunctionCell, 2004
- Diverse cellular transformation capability of overexpressed genes in human hepatocellular carcinomaBiochemical and Biophysical Research Communications, 2004
- A census of human cancer genesNature Reviews Cancer, 2004
- CCAAT/Enhancer Binding Protein α Interacts with ZTA and Mediates ZTA-Induced p21 CIP-1 Accumulation and G 1 Cell Cycle Arrest during the Epstein-Barr Virus Lytic CycleJournal of Virology, 2003
- Dual Roles of RNA Helicase A in CREB-Dependent TranscriptionMolecular and Cellular Biology, 2001
- Sequence-specific DNA Binding Activity of RNA Helicase A to the p16 PromoterPublished by Elsevier BV ,2001
- WAF1, a potential mediator of p53 tumor suppressionCell, 1993